1-2 of 2
Eleonora Russo, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rituximab Dose-Dense Chemotherapy Followed by Intensified High-Dose Chemotherapy and Autologous Stem Cell Transplantation (HDC+ASCT) Significantly Reduces the Risk of Progression Compared to Standard Rituximab Dose-Dense Chemotherapy As First Line Treatment in Young Patients with High-Risk (aa-IPI 2–3) Diffuse Large B-Cell Lymphoma (DLBCL): Final Results of Phase III Randomized Trial DLCL04 of the Fondazione Italiana Linfomi (FIL)

Umberto Vitolo, Annalisa Chiappella, Ercole Brusamolino, Emanuele Angelucci, MD, Giuseppe Rossi, Angelo Michele Carella, Andrea Evangelista, Caterina Stelitano, Monica Balzarotti, Francesco Merli, Gianluca Gaidano, MD, PhD, Vincenzo Pavone, Luigi Rigacci, MD, Francesco Zaja, MD, Nicola Cascavilla, Alfonso Maria D'Arco, Chiara Rusconi, Amalia De Renzo, Graziella Pinotti, MD, Michele Spina, Patrizia Pregno, Eleonora Russo, MD, PhD, Manuel Gotti, Alessandra Tucci, Maria Giuseppina Cabras, MD, Stefano A. Pileri, MD, Alessandro Levis, MD, Maurizio Martelli, MD
Journal: Blood
Blood (2012) 120 (21): 688.
https://doi.org/10.1182/blood.V120.21.688.688
Published: 2012
Journal Articles

Carfilzomib, Cyclophosphamide and Dexamethasone (CCd) for Newly Diagnosed Multiple Myeloma (MM) Patients

Antonio Palumbo, MD, Sara Bringhen, Oreste Villani, Agostina Siniscalchi, MD, Eleonora Russo, MD, PhD, Giuseppina Uccello, MD, Chiara Cerrato, MD, Milena Gilestro, Davide Rossi, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2012) 120 (21): 730.
https://doi.org/10.1182/blood.V120.21.730.730
Published: 2012